Profile data is unavailable for this security.
About the company
Biomm SA, formerly Savicevic Participacoes SA, is a Brazil-based company primarily engaged in the biotechnology industry. The Company is principally engaged in the development and licensing of technology for the production of human insulin and other recombinant proteins. The Company’s technology is suitable for the production of therapeutic proteins, which are used in the production of drugs and biopharmaceuticals. The Company’s technology for insulin production is protected by patents in various countries in Europe, Asia, North and South America. In addition, it is active in the development of production process of enzymes that are used in the hydrolysis of biomass and in the manufacture of bio-fuel. As of December 31, 2011, the Company’s subsidiaries were Biomm International Inc, Biomm Middle East Inc and Biomm Russia Ltd.
- Revenue in BRL (TTM)122.47m
- Net income in BRL-80.29m
- Incorporated2001
- Employees--
- LocationBiomm SAn 705,Lote 15 ao 21, AlphavilleNOVA LIMA 34.018-000BrazilBRA
- Phone+55 3 132991000
- Fax+55 3 132991021
- Websitehttps://biomm.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ouro Fino Saude Animal Participacoes SA | 954.50m | -33.72m | 1.16bn | 1.01k | -- | 1.65 | 329.49 | 1.21 | -0.6271 | -0.6271 | 17.75 | 13.03 | 0.7329 | 1.82 | 4.93 | -- | -2.59 | 5.93 | -3.17 | 7.48 | 46.45 | 49.30 | -3.53 | 7.80 | 2.55 | 59.00 | 0.3749 | 16.83 | -9.40 | 9.87 | -138.25 | -- | -0.2692 | 14.07 |
| Biomm SA | 122.47m | -80.29m | 1.83bn | -- | -- | 5.68 | -- | 14.97 | -0.9128 | -0.9128 | 1.36 | 2.55 | 0.267 | 2.27 | 3.25 | -- | -17.50 | -19.78 | -20.82 | -24.35 | 20.27 | 20.27 | -65.56 | -95.65 | 3.33 | -17.42 | 0.3235 | -- | 12.62 | 137.44 | 12.34 | -- | 40.29 | -- |
| Blau Farmaceutica SA | 1.47bn | 237.95m | 1.90bn | 1.90k | 7.94 | 0.93 | 6.77 | 1.29 | 1.33 | 1.33 | 8.24 | 11.37 | 0.5203 | 1.56 | 3.66 | 775,848.90 | 8.32 | 16.01 | 9.60 | 19.59 | 34.09 | 44.57 | 15.98 | 21.99 | 2.33 | -- | 0.2311 | 16.61 | -2.44 | 11.91 | -31.14 | 15.18 | 38.96 | -- |
| Genomma Lab Internacional SAB de CV | 5.07bn | 338.14m | 5.31bn | 1.59k | 14.78 | 1.64 | 12.81 | 1.05 | 1.14 | 1.14 | 17.28 | 10.34 | 0.764 | 2.90 | 3.66 | 10,095,660.00 | 5.09 | 5.79 | 8.21 | 8.64 | 62.23 | 61.70 | 6.67 | 7.88 | 1.32 | 2.55 | 0.3945 | 16.85 | -2.10 | 6.90 | -21.90 | -0.4465 | -26.37 | -- |
| Holder | Shares | % Held |
|---|---|---|
| WNT Gestora de Recursos Ltda.as of 16 Apr 2024 | 25.41m | 20.03% |
| BTG Pactual WM Gest�o de Recursos Ltda.as of 31 Jan 2024 | 10.01m | 7.89% |
| XP Advisory Gest�o Recursos Ltda.as of 27 Mar 2023 | 4.17m | 3.29% |
| Safra Asset Management Ltda.as of 31 Jan 2024 | 3.30m | 2.60% |
| Julius Baer Family Office Brasil Gest�o de Patrim�nio Ltdaas of 31 Jan 2024 | 3.07m | 2.42% |
| Ita� DTVM SAas of 31 Jan 2024 | 2.13m | 1.68% |
| Vinci Solu��es de Investimentos Ltda.as of 31 Jan 2024 | 184.91k | 0.15% |
| Bogari Gest�o de Investimentos Ltda.as of 31 Jan 2024 | 109.04k | 0.09% |
| BOCOM BBM CCVM SAas of 31 Jan 2024 | 100.00k | 0.08% |
| A7 Gest�o de Recursos Ltda.as of 31 Jan 2024 | 8.20k | 0.01% |
